Medical Device Regulatory Harmonization: What B2B Importers Need to Know About MDR and Asian Standards

Category: Market Trends

Regulatory harmonization means medical device rules are converging across the EU and Asia — and B2B importers who understand it can enter markets faster, cut duplicate testing, and lower compliance costs. In practice, one quality standard, ISO 13485, now underpins approvals from Brussels to Beijing, Tokyo, and Seoul, while programs like MDSAP let a single audit satisfy multiple regulators. For importers of mobility aids and rehabilitation equipment, this changes how you vet suppliers, which documents you request, and how quickly new products reach your customers. This guide explains what regulatory harmonization is, what EU MDR 2017/745 requires for Class I devices, how Asian frameworks compare, and how JiNDA positions its compliance.

Key Takeaways

EU MDR 2017/745 has been fully applicable since May 2021, raising clinical evidence, UDI, and post-market surveillance requirements.
Most mobility aids are Class I devices, but up-classification and notified body involvement are expanding.
ISO 13485 is the common quality language across the EU, NMPA, PMDA, MFDS, and FDA.
MDSAP lets one audit satisfy five regulators — the FDA, Health Canada, TGA, ANVISA, and Japan’s MHLW/PMDA.
Verifying certificates in official databases (NANDO, EUDAMED) protects importers from non-compliant supply.

What Is Regulatory Harmonization?

Regulatory harmonization is the process of aligning medical device requirements across countries so a manufacturer can meet one set of rules accepted by multiple markets. It does not mean identical laws — it means shared standards. The most important shared element is ISO 13485, the international quality management standard for medical devices, recognized by the EU, the FDA, and Asian regulators including China’s NMPA, Japan’s PMDA, and Korea’s MFDS, all members of the International Medical Device Regulators Forum (IMDRF).

What Does EU MDR 2017/745 Require for Class I Devices?

The Medical Device Regulation (MDR 2017/745) became fully applicable on 26 May 2021, replacing the Medical Devices Directive (MDD). Most mobility aids — walkers, rollators, canes, and shower chairs — fall in Class I, but MDR changed the rules even for them:

Clinical evaluation demonstrating safety and performance, proportionate to device class.
Technical documentation covering design, risk management (ISO 14971), and verification testing.
UDI and EUDAMED registration for device-level traceability.
Post-market surveillance with periodic safety update reports and vigilance reporting.
Language-compliant labels and instructions for every EU market served.

Under the amendment Regulation (EU) 2023/607, many MDD certificates remain valid until the end of 2027 or 2028 depending on device class (European Commission, 2023). The direction is clear: MDR-grade compliance is the new baseline for European sales.

How Do Asian Regulatory Frameworks Compare?

Asian regulators have aligned their systems with international standards without becoming identical:

China (NMPA). Foreign manufacturers register products through a Chinese agent; quality systems follow NMPA requirements that mirror ISO 13485.
Japan (PMDA). Manufacturers need Foreign Manufacturer Accreditation; Japan accepts MDSAP audit reports in place of on-site PMDA QMS inspections.
Korea (MFDS). Registration requires KGMP certification, which is largely based on ISO 13485, plus a local agent.

The practical effect: a supplier with a certified ISO 13485 system and complete technical files has already completed most of the work each Asian regulator requires.

What Progress Has Been Made on Mutual Recognition Agreements?

Mutual Recognition Agreements (MRAs) let regulators accept each other’s assessments, reducing duplicate work. Key progress points:

MDSAP, operational since 2017, allows one regulatory audit to satisfy five jurisdictions: US FDA, Health Canada, Australia TGA, Brazil ANVISA, and Japan MHLW/PMDA (IMDRF).
The FDA’s QMSR rule (2024) incorporates ISO 13485 by reference, effective February 2026, aligning US quality requirements with international practice.
The EU is not yet an MDSAP member, but manufacturers already in the program arrive at European assessments with audit-ready quality systems.

For importers, MDSAP participation is a reliable signal that a supplier can handle multi-market regulatory complexity.

How Do the Requirements Compare?

Requirement	EU MDR 2017/745	China NMPA	US FDA
Typical class for mobility aids	Class I	Class I–II	Class I–II
QMS basis	ISO 13485	ISO 13485-based	21 CFR 820 / QMSR (ISO 13485-based)
Registration route	CE marking, EUDAMED	NMPA registration via local agent	Establishment registration + device listing
Local representative	EU Authorised Representative	Chinese agent	US Agent
Clinical evidence	Clinical evaluation per MDR	Clinical evaluation report	510(k) equivalence or PMA

How Does Harmonization Impact B2B Trade?

Harmonization directly improves the economics of importing:

Reduced duplicate testing. A shared QMS and acceptance of MDSAP audits cut repeated factory inspections.
Faster market entry. Products certified under ISO 13485 with complete technical files move through MDR, NMPA, and FDA processes more quickly. Certification lead times of 18–24 months are common, so early, structured compliance pays.
Lower compliance cost. The European medical technology market was valued at roughly €150 billion in 2022 (MedTech Europe). Harmonization keeps compliance effort proportional to order size, especially with design families that cover buyer-specific configurations.

“Regulatory harmonization is a business advantage, not a paperwork exercise,” says Rachel Chen, Principal Consultant, MedTech Regulatory Advisory Group. “Importers who verify a supplier’s quality system and certificates up front cut months from their market-entry timeline.”

How Should B2B Importers Verify Supplier Compliance?

Before signing a supply agreement, request and verify:

Current ISO 13485 certificate with scope and audit history.
CE certificate of conformity, checked against the NANDO database.
UDI/EUDAMED registration matching the products delivered.
Test reports for load capacity, fatigue, and corrosion.
Post-market surveillance and complaint-handling documentation.

JiNDA’s Compliance Position

JiNDA Health Care has manufactured rollator walkers and rehabilitation equipment under ISO 13485 for 18 years. The company holds CE certification for European-market products, maintains FDA establishment registration, and runs a dedicated regulatory affairs team that tracks EUDAMED rollout, MDR guidance, and MDSAP expansion. Importers can contact JiNDA for certificate copies and the full product catalog with regulatory documentation.

FAQ

What is regulatory harmonization in medical devices?
Regulatory harmonization is the alignment of device requirements across countries around shared standards such as ISO 13485, so one quality system can satisfy multiple regulators.

When did EU MDR become fully applicable?
EU MDR 2017/745 became fully applicable on 26 May 2021, replacing the Medical Devices Directive.

Are mobility aids Class I medical devices under MDR?
Most mobility aids such as walkers, rollators, canes, and shower chairs are Class I devices, though some configurations require notified body involvement.

What is MDSAP, and why does it matter to importers?
MDSAP is the Medical Device Single Audit Program that lets one audit satisfy five regulators — FDA, Health Canada, TGA, ANVISA, and MHLW/PMDA — reducing duplicate inspections.

How does NMPA registration work for foreign manufacturers?
Foreign manufacturers register products with China’s NMPA through a licensed Chinese agent, with quality systems that mirror ISO 13485.

What documents should an importer request from a supplier?
Importers should request the ISO 13485 certificate, CE certificate, EU Declaration of Conformity, test reports, and post-market surveillance documentation.

Written by JiNDA Health Care | Reviewed by Dr. James Palmer, PT, DPT, ATP — Clinical Education Advisor

Last updated: August 2026